![](https://library.celltelligence.com/wp-content/uploads/2020/05/Bluebird-Earnings.png)
$0
bluebird bio Highlights Ide-cel Resubmission; Q2 2020 Earnings Call
On Wednesday, August 5, bluebird bio released their Q2 2020 financial results (press release). No new data was reported; however, the company highlighted the successful resubmission of their ide-cel BLA application. Below, Celltelligence provides insights on ide-cel’s potential approval date in the EU and a possible alternative messaging strategy for the CAR-T in earlier lines of therapy.